Peptide MGF (5 mg) PeptideSciences
oxyPharma
Price on request
View moreoxyPharma
Tirzepatide Tirzepatide (10 mg) ZPHC
Price on request
Tirzepatide ZPHC 10 mg: an innovative approach to treating type 2 diabetes and weight loss Tirzepatide 10 mg is a unique solution for patients seeking not only to improve blood sugar control, but also to manage body weight. This drug is developed for the treatment of type 2 diabetes and is based on the dual action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues. Both hormones regulate glucose levels and appetite, making tirzepatide a promising
● Out of stock
1
Tirzepatide is a dual GLP-1/GIP receptor agonist developed for the management of type 2 diabetes and body weight. By combining two complementary incretin mechanisms, it supports both blood glucose control and appetite regulation more effectively than single-pathway therapies. ZPHC's 10 mg vial supports the mid-to-upper end of a standard titration schedule.
Key Benefits
- Improves post-meal and fasting blood glucose control
- Suppresses appetite and increases satiety, supporting gradual weight loss
- Supports cardiovascular health markers relevant to metabolic disease
- Dual hormone mechanism (GLP-1 and GIP) for more comprehensive metabolic support
Reviews (0)
No reviews yet.
Related products
GHRP peptide 2 (5 mg) Nordex
oxyPharma
Price on request
View moreHexarelin Peptide (2 mg) CanadaPeptides
oxyPharma
Price on request
View moreGHRP Peptide 6 (5 mg) Nanox
oxyPharma
Price on request
View more